Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

NCT00041587 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma
Glioblastoma Multiforme
Anaplastic Astrocytoma
Mixed Oligoastrocytoma

Interventions

DRUG: IL13-PE38QQR
PROCEDURE: targeted fusion protein therapy
PROCEDURE: surgery

Sponsor

INSYS Therapeutics Inc